Abstract
Background: Despite a drastic increase among smokers using e-cigarette products in an attempt to wean off more harmful combustible cigarettes, there is no clear evidence promoting either the use of e-cigarettes (e-cigs) as a cessation device or understanding of the potential risks and benefits of these products, as per the U.S. Food and Drug Administration. Case Presentation: This case has an unusual presentation of methemoglobinemia in the emergency department for the same patient twice, immediately after using e-cigs/vapes on two separate occasions. Results: There is a possible association between e-cigarette use and methemoglobinemia. The aforementioned patient was successfully treated with the ordinary management for methemoglobinemia: methylene blue and supportive care. Conclusion: E-cigarette use has many unrecognized and possibly fatal complications. Based on our observations, we recommend a further clinical trial to study e-cigs as a causation factor for methemoglobinemia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medicine in Developing Countries
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
